title: Commentary: outcomes after escalation of infliximab in moderately active ulcerative colitis.
authors.affiliation: Department of Gastroenterology, St James's University Hospital, Leeds, UK.
authors.forename: S
authors.initials: S
authors.lastname: Halpin
authors.forename: P J
authors.initials: PJ
authors.lastname: Hamlin
mesh_terms: D000911:Antibodies, Monoclonal / Q000008:administration & dosage*; D003093:Colitis, Ulcerative / Q000188:drug therapy*; D005260:Female; D005765:Gastrointestinal Agents / Q000008:administration & dosage*; D006801:Humans; D008297:Male
chemical_list: D000911:Antibodies, Monoclonal; D005765:Gastrointestinal Agents